[Association between maternal reduced folate carrier gene polymorphisms and congenital heart disease in offspring: a case-control study].

Objective: To study the association between maternal reduced folate carrier () gene polymorphisms and congenital heart disease (CHD) in offspring.

Methods: A hospital-based case-control study was conducted. The mothers of 683 infants with CHD who attended the Department of Cardiothoracic Surgery, Hunan Children's Hospital, from November 2017 to March 2020 were enrolled as the case group. The mothers of 740 healthy infants without any deformity who attended the hospital during the same period of time were enrolled as the control group. A questionnaire survey was performed to collect the exposure data of subjects. Venous blood samples of 5 mL were collected from the mothers for genetic polymorphism detection. A multivariate logistic regression analysis was used to evaluate the association of gene polymorphisms and their haplotypes with CHD. A generalized multifactor dimensionality reduction method was used to analyze gene-gene interactions.

Results: After control for confounding factors, the multivariate logistic regression analysis showed that maternal gene polymorphisms at rs2236484 (AG AA:=1.91, 95%:1.45-2.51; GG AA: =1.96, 95%:1.40-2.75) and rs2330183 (CT CC:=1.39, 95%:1.06-1.83) were significantly associated with the risk of CHD in offspring. The haplotypes of G-G (=1.21, 95%:1.03-1.41) and T-G (=1.25, 95%:1.07-1.46) in mothers significantly increased the risk of CHD in offspring. The interaction analysis showed significant gene-gene interactions between different SNPs of the gene in CHD ( < 0.05).

Conclusions: Maternal gene polymorphisms and interactions between different SNPs are significantly associated with the risk of CHD in offspring.